Mark Kaplan, MD
Surgery · Philadelphia, PANPI 1376649277
Payments from drug & device makers
Across 49 payments — averaging $584.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$19K
- Solventum Corporation$9K
- Baxter Healthcare$165
- Boston Scientific$156
- Integra Lifesciences Corporation$84
- Johnson & Johnson$32
- plus $107 from 6 others
What the payments were for
- Consulting fees$8,95531%
- Speaking & faculty fees$18,70065%
- Food & beverage$9773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 25 | $18,746 |
| Solventum Corporation | 7 | $9,342 |
| Baxter Healthcare | 2 | $165 |
| Boston Scientific | 2 | $156 |
| Integra Lifesciences Corporation | 4 | $84 |
| Johnson & Johnson(2 entities) | 2 | $32 |
| Smith+Nephew | 2 | $30 |
| Vertex | 1 | $22 |
| Baudax Bio Inc. | 1 | $21 |
| Clovis Oncology, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Z-medica, LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$20,061
- ABTHERA$19,350
- ABTHERA ADVANCE$11,700
- V.A.C. VERAFLO$9,450
- 3M Cavilon$7,950
- V.A.C. ULTA$4,200
- 3M SoluPrep$3,600
- ACTIV.A.C.$1,125
- PROMOGRAN PRISMA$1,050
- 3M Ioban$600
- Ioban 2$600
- GRANUFOAM$550
- V.A.C. SIMPLACE$550
- PROMOGRAN$300
- 3M DuraPrep Surgical$275
- DERMATAC$275
- KERRACEL AG$275
- V.A.C. VERAFLO CLEANSE CHOICE$275
- PerClot$137
How this compares
$28,633 in reported general payments places this provider in the 90th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Philadelphia
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Olwadamilola FayanjuPhiladelphia$668K
- Julia TchouPhiladelphia$555K
- Ali NajiPhiladelphia$539K
- Ashesh ShahPhiladelphia$328K
- Lisa RaePhiladelphia$318K
- Hooman YarmohammadiPhiladelphia$304K
- Arminder JassarPhiladelphia$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.